GlassScriptPhysician profile
Amandeep Singh
NPI 1922356898
$1,675.07
in general payments reported to CMS, 2019-2025
22 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $277 · 2021: $126 · 2022: $103 · 2023: $183 · 2024: $293 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $440.47 | 2019-2025 | Jardiance |
| Braeburn INC. | $247.84 | 2023-2025 | Brixadi |
| Amgen INC. | $208.00 | 2020-2025 | Evenity, Prolia |
| Allergan, INC. | $102.73 | 2019-2020 | |
| Lilly USA, LLC | $101.47 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Indivior INC. | $93.94 | 2019-2024 | Sublocade |
| Merck Sharp & Dohme LLC | $89.28 | 2021-2025 | Capvaxive |
| Glaxosmithkline, LLC. | $60.62 | 2020-2024 | Trelegy Ellipta |
| Pfizer INC. | $53.27 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $45.00 | 2020 | |
| Abbvie INC. | $44.52 | 2022-2025 | |
| Atricure, INC. | $31.60 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kowa Pharmaceuticals America, INC. | $29.62 | 2019-2025 | Zoryve |
| Gilead Sciences, INC. | $28.77 | 2019 | |
| Abbott Laboratories | $16.85 | 2023 | Freestyle Libre 3 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $15.93 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.59 | 2019 | |
| Biodelivery Sciences International, INC. | $13.09 | 2020 | |
| Orexo US, INC. | $12.71 | 2019 | |
| Viiv Healthcare Company | $11.58 | 2021 | |
| Novo Nordisk INC | $11.02 | 2020 | |
| Dynavax Technologies Corporation | $2.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amandeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.